DEVYSER DIAGNOSTICS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 103 SEK | -1.90% |
|
+0.49% | +31.04% |
| 04-25 | Devyser Receives IVDR Approval for Post-Transplant Monitoring Software | CI |
| 03-11 | Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test | CI |
Quotes 5-day view
Delayed Quote Nasdaq Stockholm| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | 2024-04-29 | |
|---|---|---|---|---|---|
| Last | 104 kr | 102.5 kr | 103 kr | 105 kr | 103 kr |
| Volume | 12 234 | 455 | 4 243 | 2 387 | 4 057 |
| Change | +1.46% | -1.44% | +0.49% | +1.94% | -1.90% |
| Opening | 103.00 | 105.00 | 102.50 | 104.50 | 105 |
| High | 107.00 | 105.00 | 105.00 | 105.00 | 105 |
| Low | 103.00 | 102.50 | 102.00 | 103.50 | 102.5 |
Performance
| 1 day | -1.90% | ||
| 1 week | +0.49% | ||
| Current month | +1.48% | ||
| 1 month | +1.98% | ||
| 3 months | +18.39% | ||
| 6 months | +66.13% | ||
| Current year | +31.04% | ||
| 1 year | +21.46% |
Volumes
marketsDaily volume
4 057
Estimated daily volume
6 548
Avg. Volume 20 sessions
7 518
Daily volume ratio
0.87
Avg. Volume 20 sessions SEK
774 354.00
Avg. Volume 20 sessions USD
70 993.55
Record volume 1
480 953
Record volume 2
413 543
Record volume 3
256 893
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (SEK)
1 701 016 754
Capitalization (USD)
155 950 917
Net sales (SEK)
169 300 000
Net sales (USD)
15 521 593
Number of employees
118
Sales / Employee (SEK)
1 434 746
Sales / Employee (USD)
131 539
Free-Float
51.4 %
Free-Float capitalization (SEK)
874 361 462
Free-Float capitalization (USD)
80 162 333
Average Daily Capital Traded
0.05%
Highs and lows
1 week
102.00
107.00
1 month
100.00108.50
Current year
76.20109.00
1 year
57.40109.00
3 years
56.10109.00
5 years
56.10109.00
10 years
56.10109.00
Indicators
Moving average 5 days
103.40
Moving average 20 days
103.68
Moving average 50 days
96.62
Moving average 100 days
89.17
Price spread / (MMA5)
+0.39%
Price spread / (MMA20)
+0.66%
Price spread / (MMA50)
-6.19%
Price spread / (MMA100)
-13.43%
STIM
RSI 9 days
49.95
RSI 14 days
54.79
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.90% | +0.49% | +31.04% | +21.46% | 156M | ||
| +0.38% | +2.98% | +1.51% | +24.78% | 42.75B | ||
| -0.55% | +3.55% | +48.37% | -5.17% | 41.61B | ||
| +1.69% | +6.47% | +8.57% | -18.75% | 41.34B | ||
| -0.45% | +2.14% | -12.36% | +9.96% | 26.59B | ||
| +2.74% | +6.97% | +8.92% | +60.00% | 25.49B | ||
| -0.28% | -0.76% | -25.13% | -28.06% | 18.12B | ||
| +1.58% | +6.43% | +29.17% | +97.83% | 12.24B | ||
| +0.54% | +0.99% | -3.12% | +20.47% | 11.76B | ||
| -0.89% | -1.71% | +6.35% | +1.62% | 11B | ||
| +2.23% | +3.12% | -16.98% | -19.80% | 10.07B | ||
| +1.39% | +4.12% | -6.98% | -9.44% | 9.22B | ||
| -1.17% | +2.30% | +23.38% | -16.15% | 6.65B | ||
| +8.85% | +16.24% | +4.97% | -36.57% | 6.44B | ||
| +1.78% | +2.98% | +25.38% | +53.09% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +0.90% | +3.47% | +8.21% | +10.35% | ||
| Weighted average by Cap. | +0.68% | +3.69% | +8.82% | +9.31% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
c3ef29114230f3a220408a08.F_3GwgsnusACkCch7ZXrUn8HqvSLz2MaIOJAErF9Mjw.SI6Q8HpU4_J3pR54iNzbITh_nZG-_iFdaKh4Wu41fF9vlK-ER37ek3TkRA
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 07:48:19 | 103 | 325 | 4,057 |
| 07:48:19 | 103 | 75 | 3,732 |
| 06:46:26 | 102.5 | 9 | 3,657 |
| 06:46:26 | 102.5 | 1 | 3,648 |
| 06:12:42 | 103 | 145 | 3,647 |
| 06:08:37 | 102.5 | 10 | 3,502 |
| 06:08:37 | 102.5 | 206 | 3,492 |
| 06:08:37 | 102.5 | 16 | 3,286 |
| 06:08:37 | 102.5 | 700 | 3,270 |
| 06:08:37 | 102.5 | 297 | 2,570 |
Monthly variations
Annual change
| 2024 | +33.59% | ||
| 2023 | +9.17% | ||
| 2022 | -18.74% | ||
| 2021 | -0.45% |
- Stock Market
- Equities
- DVYSR Stock
- Quotes Devyser Diagnostics AB
